Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease undergoing endovascular therapy

Journal of Vascular Surgery

Volumn 61, Issue 5, 2015, Pages 1223-1230

  Kim, Gwang Sil ^a   Ko, Young Guk ^a   Shin, Dong Ho ^a   Kim, Jung Sun ^a   Kim, Byeong Keuk ^a   Choi, Donghoon ^a   Hong, Myeong Ki ^a   Jang, Yangsoo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; CYSTATIN C; IODIXANOL; BIOLOGICAL MARKER; CONTRAST MEDIUM;

ADVERSE OUTCOME; AGED; AMPUTATION; ANKLE BRACHIAL INDEX; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DYSLIPIDEMIA; ENZYME BLOOD LEVEL; EVENT FREE SURVIVAL; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; INVESTIGATIVE PROCEDURES; KIDNEY FUNCTION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; ADVERSE EFFECTS; ANGIOGRAPHY; ANGIOPLASTY; ARTERIAL OCCLUSIVE DISEASES; BLOOD; CHEMICALLY INDUCED; DIAGNOSTIC USE; INTERMITTENT CLAUDICATION; ISCHEMIA; KIDNEY FAILURE; KIDNEY FUNCTION TEST; LEG; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RISK FACTOR; VASCULARIZATION;

AGED; ANGIOGRAPHY; ANGIOPLASTY; ARTERIAL OCCLUSIVE DISEASES; BIOLOGICAL MARKERS; CONTRAST MEDIA; CREATININE; CYSTATIN C; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; KIDNEY FUNCTION TESTS; LEG; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84929029327     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2014.11.079     Document Type: Article

References (29)

1. M. Abrahamson, I. Olafsson, A. Palsdottir, M. Ulvsback, A. Lundwall, O. Jensson et al. Structure and expression of the human cystatin C gene Biochem J 268 1990 287 294
2. O. Tenstad, A.B. Roald, A. Grubb, and K. Aukland Renal handling of radiolabelled human cystatin C in the rat Scand J Clin Lab Invest 56 1996 409 414
3. V.R. Dharnidharka, C. Kwon, and G. Stevens Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis Am J Kidney Dis 40 2002 221 226
4. C. Briguori, G. Visconti, N.V. Rivera, A. Focaccio, B. Golia, R. Giannone et al. Cystatin C and contrast-induced acute kidney injury Circulation 121 2010 2117 2122
5. A. Odutayo, and D. Cherney Cystatin C and acute changes in glomerular filtration rate Clin Nephrol 78 2012 64 75
6. C.M. O'Seaghdha, A. Tin, Q. Yang, R. Katz, Y. Liu, T. Harris et al. Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality Am J Kidney Dis 63 2014 16 22
7. G. Urbonaviciene, G.P. Shi, S. Urbonavicius, E.W. Henneberg, and J.S. Lindholt Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease Atherosclerosis 216 2011 440 445
8. K. Nash, A. Hafeez, and S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 2002 930 936
9. A. Aurelio, and A. Durante Contrast-induced nephropathy in percutaneous coronary interventions: pathogenesis, risk factors, outcome, prevention and treatment Cardiology 128 2014 62 72
10. G.M. Welten, O. Schouten, S.E. Hoeks, M. Chonchol, R. Vidakovic, R.T. van Domburg et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease J Am Coll Cardiol 51 2008 1588 1596
11. P.A. McCullough Contrast-induced acute kidney injury J Am Coll Cardiol 51 2008 1419 1428
12. L.A. Stevens, J. Coresh, T. Greene, and A.S. Levey Assessing kidney function - measured and estimated glomerular filtration rate N Engl J Med 354 2006 2473 2483
13. C.S. Rihal, S.C. Textor, D.E. Grill, P.B. Berger, H.H. Ting, P.J. Best et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 2002 2259 2264
14. R. Mehran, E.D. Aymong, E. Nikolsky, Z. Lasic, I. Iakovou, M. Fahy et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 2004 1393 1399
15. F. Luders, N. Malyar, M. Meyborg, K. Gebauer, E. Brand, and H. Reinecke Impact of peripheral arterial occlusive disease on the development of contrast medium-induced acute kidney injury Nephron Clin Pract 122 2012 38 43
16. F.H. Artunc, I.U. Fischer, T. Risler, and C.M. Erley Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization Int J Cardiol 102 2005 173 178
17. R. Orlando, M. Mussap, M. Plebani, P. Piccoli, S. De Martin, M. Floreani et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis Clin Chem 48 2002 850 858
18. B. Stabuc, L. Vrhovec, M. Stabuc-Silih, and T.E. Cizej Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy Clin Chem 46 2000 193 197
19. I. Helin, M. Axenram, and A. Grubb Serum cystatin C as a determinant of glomerular filtration rate in children Clin Nephrol 49 1998 221 225
20. K. Kato, N. Sato, T. Yamamoto, Y.K. Iwasaki, K. Tanaka, and K. Mizuno Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization Circ J 72 2008 1499 1505
21. A. Wacker-Gussmann, K. Buhren, C. Schultheiss, S.L. Braun, S. Page, B. Saugel et al. Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients AJR Am J Roentgenol 202 2014 452 458
22. F. Ribichini, G. Gambaro, M.S. Graziani, M. Pighi, G. Pesarini, P. Pasoli et al. Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions Clin Chem 58 2012 458 464
23. M.G. Shlipak, R. Katz, M.J. Sarnak, L.F. Fried, A.B. Newman, and C. Stehman-Breen Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease Ann Intern Med 145 2006 237 246
24. J.H. Ix, M.G. Shlipak, G.M. Chertow, and M.A. Whooley Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study Circulation 115 2007 173 179
25. D. Silva, N. Cortez-Dias, C. Jorge, J.S. Marques, P. Carrilho-Ferreira, A. Magalhaes et al. Cystatin C as prognostic biomarker in ST-segment elevation acute myocardial infarction Am J Cardiol 109 2012 1431 1438
26. M.G. Shlipak, R. Katz, L.F. Fried, N.S. Jenny, C. Stehman-Breen, and A.B. Newman Cystatin-C and mortality in elderly persons with heart failure J Am Coll Cardiol 45 2005 268 271
27. L. Ni, J. Lu, L.B. Hou, J.T. Yan, Q. Fan, R. Hui et al. Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese Stroke 38 2007 3287 3288
28. F. Liu, J. Shen, J. Zhao, H. Zeng, L. Li, J. Zhao et al. Cystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients? PLoS One 8 2013 e66907
29. A.M. O'Hare, A.B. Newman, R. Katz, L.F. Fried, C.O. Stehman-Breen, S.L. Seliger et al. Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study Arch Intern Med 165 2005 2666 2670